Navigation Links
China’s AIDS vaccine-successfully finishes first phas

According to the government health officials, initial clinical trials show that China’s first AIDS vaccine is safe and probably effective//.

"Forty-nine healthy people who received the injections showed no severe adverse reactions after 180 days, proving the vaccine was safe," said Zhang Wei, head of the pharmaceutical registration department of the State Food and Drug Administration (SFDA).

"The recipients appeared immune to the HIV-1 virus 15 days after the injection, indicating the vaccine worked well in stimulating the body's immunity," he told a press conference in Beijing.

The first phase of clinical trials, which focused on the vaccine’s safety comes to an end with these results.

Sang Guowei, director of the National Institute for the Control of Pharmaceutical and Biological Products, said that the second-round tests will require at least 300 volunteers and the third phase at least 500.

According to Chen Jie, deputy director of the Guangxi Regional Center for Disease Control and Prevention, participation of high-risk groups will be involved in the later trials.

The first phase of clinical trials began in March 2005 in Nanning, which is the capital of the Guangxi Zhuang Autonomous Region. 33 men and 16 women aged between 18 and 50 years, volunteered for this trial. They were divided into 8 groups, of which, 6 groups were given a single AIDS vaccine and the others were injected with a combined AIDS vaccine. This was reported by the Guangxi center for disease control.

”The HIV-1 specific cells injected into the recipients were the DNA fragments of the virus that don't cause infection,” Sang said.

”Some recipients' cells and body fluids in the combined group appeared immune to the HIV-1 virus.”

Kong Wei, leader of the research team and a professor at Jilin University said, ”A total 344 blood samples were taken from the volunteers, with each one donating five to 10 samples.”

The volunteers exhibited no serious ill effects even after 180 days of observation.

According to the SFDA officials, the scientists will continue analysis of the results of the first phase, before SFDA approves the beginning of the second phase, after a rigorous assessment.

Assessment of safety and immunity comprises the second phase while the third is concerned with how the vaccine will provide protection to the high-risk groups.

According to the 2005 Update on the HIV/AIDS Epidemic and Response in China, 6,50,000 people in this country are living with HIV/AIDS while 75,000 with clinical AIDS.

Scientists and other experts concerned with the drastic increase in the spread of the disease, urged the State Council, China's cabinet, to raise funding for and encourage innovation and cooperation in research.

International funding worth 123.2 million U.S. dollars was given to China recently by the Global Fund to Fight HIV/AIDS, Tuberculosis and Malria.
'"/>




Related medicine news :

1. Mystery over bird flu infection to Ms. Zhou – China’s 7th bird flu victm
2. Lower Birth Rate and Fewer Girls under China’s one Child Polic
3. Infant receives first bloodless liver transplant
4. Oracle Corp. to help build worlds first "Digital Hospital"
5. FDA approves first pocket-sized EKG machine
6. Valerian was first epilepsy drug
7. New device for ailing heart fitted into first patient
8. Canada helps in giving birth to world first baby from frozen egg
9. SNUPPY – Woo Suk Hwang reveals World’s first dog cloe
10. Successful creation of human embryos from a single parent for the first time
11. A first for India - IVF baby born of surrogacy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... ... June 28, 2017 , ... Guide to FDA and EU Medical Device Regulations: ... which side of the Atlantic devicemakers do business, this fully updated and expanded guide ... In addition to the full text of the FDA’s regulations in 21 CFR Parts ...
(Date:6/28/2017)... ... ... remote control has seen the never-ending twists on the house flipping show genre. The shows ... time. But what about the buyers of the flipper's flip. , Here is ... An email recently sent to Gary Case said, “Just closed on a home on ...
(Date:6/28/2017)... , ... June 28, 2017 , ... David B. Sosin, a founding partner ... took over the post of 2nd Vice President for the Illinois State Bar Association ... as the ISBA’s 3rd Vice President in 2016 following a state-wide election and served in ...
(Date:6/28/2017)... FL (PRWEB) , ... June 28, 2017 , ... American ... an upcoming episode of the award winning television series, scheduled to broadcast fourth quarter ... Line Seeds originated as a regional supplier of garden pea seed. As demand grew, ...
(Date:6/28/2017)... ... 28, 2017 , ... Canadian Zeolite Corp. (the “Company”) (TSX.V: ... study conducted by the University of Saskatchewan in partnership with PotashCorp, Agrium and ... groundwater. As a part of the study, batch adsorption experiments were conducted with ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/8/2017)... 2017  StatLab Medical Products ("StatLab" or ... of diagnostic supplies for the anatomic pathology ... Company LP ("Cressey & Company"), a healthcare-focused ... investment in the Company. Cressey & Company ... selling shareholder, Prairie Capital, L.P., with certain ...
(Date:6/5/2017)... CINCINNATI , June 5, 2017 The ... a brand of Diplomat Pharmacy, Inc. (NYSE: DPLO), has been ... Cincinnati Enquirer . Results are based on ... specializing in organizational health and workplace improvement. The survey measures ... ...
Breaking Medicine Technology: